Participación integral del laboratorio clínico como herramienta de diagnóstico en el linfoma de Burkitt: Articulo de revisión
Article Sidebar
Publicado
abr 16, 2026
##plugins.pubIds.doi.readerDisplayName##
https://doi.org/10.36677/medicinainvestigacion.v14i1.24420
Main Article Content
Ignacio Uriel Macias Paz
Ariadna Hernández Pérez
http://orcid.org/0009-0008-5383-6297
Rubén López Hernández
http://orcid.org/0009-0000-5643-5909
María Adriana González Flores
http://orcid.org/0009-0003-0061-1338
http://orcid.org/0009-0008-5383-6297
Rubén López Hernández
http://orcid.org/0009-0000-5643-5909
María Adriana González Flores
http://orcid.org/0009-0003-0061-1338
Resumen
El linfoma de Burkitt (lb) es un linfoma de células b no Hodgkin con alta incidencia en países del continente africano y en el mundo que se caracteriza por su rápido crecimiento y por su agresividad. A pesar de los grandes avances en la oncología, aún hace falta reconocer el diagnóstico oportuno por parte del equipo de trabajo del área de la salud. En esta revisión hemos contribuido en el estudio de la etiología, epidemiologia, cuadro clínico y patogenia del lb. Además, se revisan los distintos métodos diagnósticos que existen en la actualidad para la participación integral en salud.
TRANSLATE with x
English
Arabic
Hebrew
Polish
Bulgarian
Hindi
Portuguese
Catalan
Hmong Daw
Romanian
Chinese Simplified
Hungarian
Russian
Chinese Traditional
Indonesian
Slovak
Czech
Italian
Slovenian
Danish
Japanese
Spanish
Dutch
Klingon
Swedish
English
Korean
Thai
Estonian
Latvian
Turkish
Finnish
Lithuanian
Ukrainian
French
Malay
Urdu
German
Maltese
Vietnamese
Greek
Norwegian
Welsh
Haitian Creole
Persian
TRANSLATE with
COPY THE URL BELOW
Back
EMBED THE SNIPPET BELOW IN YOUR SITE
Enable collaborative features and customize widget: Bing Webmaster Portal
Back
Article Details
Como citar
MACIAS PAZ, Ignacio Uriel et al.
Participación integral del laboratorio clínico como herramienta de diagnóstico en el linfoma de Burkitt: Articulo de revisión.
Medicina e Investigación Universidad Autónoma del Estado de México, [S.l.], v. 14, n. 1, p. 108-117, abr. 2026.
ISSN 2594-0600.
Disponible en: <https://medicinainvestigacion.uaemex.mx/article/view/24420>. Fecha de acceso: 18 ago. 2026
doi: https://doi.org/10.36677/medicinainvestigacion.v14i1.24420.
Número
Sección
Artículos de revisión
Esta obra está bajo licencia internacional Creative Commons Reconocimiento-NoComercial-SinObrasDerivadas 4.0.
Citas
Burkitt D. A sarcoma involving the jaws in african children. British Journal of Surgery [Internet]. 1958 Nov; 46(197): 218–23. doi: 10.1002/bjs.18004619704.
Sarkin Jaffe E, Lee Harris N, Vardiman J, A. Arber D, Campo E. Hematopathology [Internet]. 1st ed. Saunders; 5AD. Disponible en: https://books.google.com.pr/books?id=tlCcjz94rlkC&printsec=frontcover#v=onepage&q&f=false.
Morrow Rh. Epidemiological evidence for the role of falciparum malaria in the pathogenesis of Burkitt’s lymphoma. IARC Sci Publ [Internet]. 1985 Jan 1; (60): 177–86. Disponible en: https://pubmed.ncbi.nlm.nih.gov/3905588/.
Orem J, Mbidde EK, Lambert B, de Sanjose S, Weiderpass E. Burkitt’s lymphoma in Africa, a review of the epidemiology and etiology. African health sciences [Internet]. 2007; 7(3): 166–75. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2269718/.
Shaymaa Elgaafary, López C, Nagel I, Vater I, Bens S, Szczepanowski M, et al. Molecular characterization of Burkitt lymphoma in the breast or ovary. Leukemia & lymphoma/Leukemia and lymphoma [Internet]. 2021 Jun 24; 62(9): 2120–9. doi: 10.1080/10428194.2021.1907374. Disponible en: https://www.tandfonline.com/doi/full/10.1080/10428194.2021.1907374.
Richter J, John K, Staiger AM, Rosenwald A, Kurz K, Michgehl U, et al. Epstein–Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. British Journal of Haematology [Internet]. 2021 Oct 6; 196(3): 681–9. doi: 10.1111/bjh.17874.
Singh S, Patel S, Sahu C, Ghoshal U, Verma H. A three year Seroepidemiological and molecular study of Epstein –Barr virus infection among different age groups with hematological malignancies in a Tertiary care centre of North India (2017-2019). Journal of Family Medicine and Primary Care [Internet]. 2021; 10(1): 373. doi: 10.4103/jfmpc.jfmpc_1594_20.
Anderson AG, Gaffy CB, Weseli JR, Gorres KL. Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine. Viruses [Internet]. 2019 May 17; 11(5): 450. doi: 10.3390/v11050450.
Messick TE, Smith GR, Soldan SS, McDonnell ME, Deakyne JS, Malecka KA, et al. Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth. Science Translational Medicine [Internet]. 2019 Mar 6; 11(482). doi: 10.1126/scitranslmed.aau5612.
Liao HM, Liu H, Chin PJ, Li B, Hung GC, Tsai S, et al. Epstein-Barr Virus in Burkitt Lymphoma in Africa Reveals a Limited Set of Whole Genome and LMP-1 Sequence Patterns: Analysis of Archival Datasets and Field Samples From Uganda, Tanzania, and Kenya. Frontiers in Oncology [Internet]. 2022 Mar 7;12. doi: 10.3389/fonc.2022.812224.
Xian RR, Kinyera T, Otim I, Sampson JN, Nabalende H, Legason ID, et al. Plasma EBV DNA: A Promising Diagnostic Marker for Endemic Burkitt Lymphoma. Frontiers in Oncology [Internet]. 2021 Dec 14; 11: 804083. doi: 10.3389/fonc.2021.804083.
Torres Coral, Santana Josefina, Bravo Rodrigo, Córdova Luis, Rodríguez Ximena, Mardones Marcelo. Linfoma de Burkitt asociado a Virus de la Inmunodeficiencia Humana. Reporte de un caso clínico. Rev. Clin. Periodoncia Implantol. Rehabil. Oral [Internet]. 2019 Dic; 12(3): 148-150. doi: http://dx.doi.org/10.4067/S0719-01072019000300148.
Salud S de. Linfoma, enfermedad oncológica que puede ser curable [Internet]. gob.mx. Disponible en: https://www.gob.mx/salud/es/articulos/linfoma-enfermedad-oncologica-que-puede-ser-curable?idiom=es.
Cerron-Vela CR, Araujo-Banchon WJ. Linfoma de Burkitt de la calota craneana: a propósito de un caso. Revista de la Facultad de Ciencias Médicas de Córdoba [Internet]. 2020 Apr 14; 77(2): 106–9. doi: https://doi.org/10.31053/1853.0605.v77.n2.26764.
Pourghasemian M, Amin Danandeh Mehr E, Elaheh Alavizadeh, Roosta Y, Behzadi F. Primary bilateral ovarian involvement in Burkitt’s lymphoma with an adnexal Torsion‐like manifestation: A case report. Clinical Case Reports [Internet]. 2021 Nov 1; 9(11). doi: 10.1002/ccr3.5058.
Goel AN, Filimonov A, Teruya-Feldstein J, Salib C, Rousso JJ, Hackett AM, et al. Burkitt lymphoma of the nasopharynx causing life-threatening airway obstruction: A case report. American Journal of Otolaryngology [Internet]. 2021; 42(4): 102977. doi: 10.1016/j.amjoto.2021.102977.
Perkins AS, Friedberg JW. Burkitt Lymphoma in Adults. Hematology [Internet]. 2008 Jan 1;2008(1):341–8. doi: 10.1182/asheducation-2008.1.341. Disponible en: https://ashpublications.org/hematology/article/2008/1/341/95852/Burkitt-Lymphoma-in-Adults.
Pannone G, Zamparese R, Pace M, Pedicillo M, Cagiano S, Somma P, et al. The role of EBV in the pathogenesis of Burkitt’s Lymphoma: an Italian hospital based survey. Infectious Agents and Cancer [Internet]. 2014; 9(1): 34. doi: 10.1186/1750-9378-9-34.
Stepniak A, Piotr Czuczwar, Piotr Szkodziak, Wozniakowska E, Wozniak S, Paszkowski T. Primary ovarian Burkitt’s lymphoma: a rare oncological problem in gynaecology: a review of literature. Archives of gynecology and obstetrics [Internet]. 2017 Aug 2; 296(4): 653–60. doi: 10.1007/s00404-017-4478-6.
Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G, et al. Burkitt’s lymphoma. The Lancet [Internet]. 2012 Mar; 379(9822): 1234–44. doi: 10.1016/S0140-6736(11)61177-X. [
Storck K, Brandstetter M, Keller U, Knopf A. Clinical presentation and characteristics of lymphoma in the head and neck region. Head & Face Medicine [Internet]. 2019 Jan 3; 15(1). doi: 10.1186/s13005-018-0186-0.
Ospina Pérez M, Muñetón Peña CM. Alteraciones del gen c-Myc en la oncogénesis. Iatreia [Internet]. 2011 Dec; 24(4): 389-401. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-07932011000400006&lng=en.
Gálvez Paz CN, Mendoza Goycochea ME, Espíritu N, Paz Carrillo EM, Gálvez Paz CN, Mendoza Goycochea ME, et al. Características clínicas, epidemiológicas y patológicas de los linfomas en pacientes del Instituto Nacional de Salud del Niño de Breña - Perú, 2015-2019. Anales de la Facultad de Medicina [Internet]. 2021 Mar 1; 82(1): 27–33. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832021000100027.
Bidot S, Asakrah, S. Burkitt lymphoma [Internet]. www.pathologyoutlines.com. 2021 Disponible en: https://www.pathologyoutlines.com/topic/lymphomaburkitt.
Melenotte C, Mezouar S, Mège JL, Gorvel JP, Kroemer G, Raoult D. Bacterial infection and non-Hodgkin’s lymphoma. Critical Reviews in Microbiology [Internet]. 2020 May 1; 46(3): 270–87. doi: 10.1080/1040841X.2020.1760786.
Coelho R, Gonçalves R, Costa J, Macedo G. Burkitt’s Lymphoma Diagnosed by Colonoscopy in Immunocompetent Patient. GE Portuguese Journal of Gastroenterology [Internet]. 2015 May 1; 22(3): 130–1. doi: 10.1016/j.jpge.2015.02.002.
Latorre-Rodríguez Andrés Ricardo, Rodríguez-Chavarría María Angélica, Acosta-Forero Bernarda Jinneth, Ricaurte-Guerrero Orlando. Linfoma no Hodgkin primario de ovario: reporte de caso y revisión de la bibliografía. Ginecol. obstet. Méx. [Internet]. 2022; 90(9): 794-802. doi: 10.24245/gom.v90i9.5722.
Aragón Flores M, Pérez Zincer F, Pérez Salvador A, Roldán A, Gaspar López A. Linfoma de Burkitt, presentación de un caso y abordaje diagnóstico. Revista de Sanidad Militar [Internet]. 2012; 66: 272–7. Disponible en: https://www.imbiomed.com.mx/articulo.php?id=88564.
Arboine Ciphas Maureen. Linfoma de burkitt: a propósito de un caso. Med. leg. Costa Rica [Internet]. 2017 Mar; 34(1): 325-331. Disponible en: http://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S1409-00152017000100325&lng=en.
Jacobson C, LaCasce A. How I treat Burkitt lymphoma in adults. Blood [Internet]. 2014 Nov 6; 124(19): 2913–20. doi: 10.1182/blood-2014-06-538504.
Arseneau JC, Canellos GP, Banks PA, Berard CW, Gralnick HR, DeVita VT. American Burkitt’s lymphoma: A clinicopathologic study of 30 cases [Internet]. 1975 Mar 1; 58(3): 314–21. doi: 10.1016/0002-9343(75)90598-7.
Graham BS, Lynch DT. Burkitt Lymphoma. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2023. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK538148/.
Ferry JA. Burkitt’s Lymphoma: Clinicopathologic Features and Differential Diagnosis. The Oncologist [Internet]. 2006 Apr 1; 11(4): 375–83. doi: 10.1634/theoncologist.11-4-375.
Suárez A. Síndrome de lisis tumoral: un enfoque pediátrico. Revista Colombiana de Cancerología [Internet]. 2004 Jun 1; 8(2): 31–9. Disponible en: http://www.scielo.org.co/pdf/rcc/v8n2/v8n2a05.pdf.
De Soto Cardenal M, Coronel Villarán MJ, Prat Gutierrez R. Linfoma de Burkitt ovárico bilateral. Progresos de Obstetricia y Ginecología [Internet]. 2015 Dec. Disponible en: https://sego.es/documentos/progresos/v59-2016/n5/13_Linfoma.pdf.
Alexander CJ, Wake LM. Educational Case: Burkitt Lymphoma. Academic Pathology [Internet]. 2019 Jan 1; 6: 237428951988473. doi: 10.1177/2374289519884733.
Chong Y, Kim TE, Cho U, Jin MS, Yim K, Thakur N, et al. Comparison of Ki-67 Labeling Index Patterns of Diffuse Large B-Cell Lymphomas and Burkitt Lymphomas Using Image Analysis: A Multicenter Study. Diagnostics [Internet]. 2021 Feb 19; 11(2): 343. doi: 10.3390/diagnostics11020343.
Hambach J, Riecken K, Cichutek S, Schütze K, Albrecht B, Petry K, et al. Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs). Cells [Internet]. 2020 Jan 29; 9(2): 321–1. doi: 10.3390/cells9020321. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072387/.
Lindström MS, Klangby U, Wiman KG. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53. Oncogene [Internet]. 2001 Apr; 20(17): 2171–7. doi: 10.1038/sj.onc.1204303.
Klanova M, Dmitry Kazantsev, Pokorna E, Zikmund T, Karolova J, Behounek M, et al. Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas. Molecular Cancer Therapeutics [Internet]. 2021 Nov 2; 21(1): 89–99. doi: 10.1158/1535-7163.MCT-21-0511.
Schwabkey ZI, Najla Al Ali, Chan O, Sallman DA, Padron E, Kuykendall AT, et al. Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype. Clinical Lymphoma Myeloma & Leukemia [Internet]. 2021 Jan 1; 21(1): e52–6. doi: 10.1016/j.clml.2020.08.012.
Chrzanowska NM, Kowalewski J, Lewandowska MA. Use of Fluorescence In Situ Hybridization (FISH) in Diagnosis and Tailored Therapies in Solid Tumors. Molecules [Internet]. 2020 Apr 17; 25(8). doi: 10.3390/molecules25081864.
Asif A, Mushtaq S, Hassan U, Akhtar N, Hussain M, Azam M, et al. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas. Asian Pacific Journal of Cancer Prevention: APJCP [Internet]. 2018; 19(3): 655–60. doi: 10.22034/APJCP.2018.19.3.655.
Savic S, Bubendorf L. Common Fluorescence In Situ Hybridization Applications in Cytology. Archives of Pathology & Laboratory Medicine [Internet]. 2016 Dec 1; 140(12): 1323–30. doi: 10.5858/arpa.2016-0202-RA.
Nelson M, Perkins SL, Davé BJ, Coccia PF, Bridge JA, Lyden E, et al. An increased frequency of 13q deletions detected by fluorescencein situhybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children’s Oncology Group study CCG-5961. British Journal of Haematology [Internet]. 2010 Feb 1; 148(4): 600–10. doi: 10.1111/j.1365-2141.2009.07967.x.
Robertson ES. Burkitt’s Lymphoma. Springer eBooks. Springer Nature [Internet]. 2013. Disponible en: https://link.springer.com/book/10.1007/978-1-4614-4313-1.
Sarkin Jaffe E, Lee Harris N, Vardiman J, A. Arber D, Campo E. Hematopathology [Internet]. 1st ed. Saunders; 5AD. Disponible en: https://books.google.com.pr/books?id=tlCcjz94rlkC&printsec=frontcover#v=onepage&q&f=false.
Morrow Rh. Epidemiological evidence for the role of falciparum malaria in the pathogenesis of Burkitt’s lymphoma. IARC Sci Publ [Internet]. 1985 Jan 1; (60): 177–86. Disponible en: https://pubmed.ncbi.nlm.nih.gov/3905588/.
Orem J, Mbidde EK, Lambert B, de Sanjose S, Weiderpass E. Burkitt’s lymphoma in Africa, a review of the epidemiology and etiology. African health sciences [Internet]. 2007; 7(3): 166–75. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2269718/.
Shaymaa Elgaafary, López C, Nagel I, Vater I, Bens S, Szczepanowski M, et al. Molecular characterization of Burkitt lymphoma in the breast or ovary. Leukemia & lymphoma/Leukemia and lymphoma [Internet]. 2021 Jun 24; 62(9): 2120–9. doi: 10.1080/10428194.2021.1907374. Disponible en: https://www.tandfonline.com/doi/full/10.1080/10428194.2021.1907374.
Richter J, John K, Staiger AM, Rosenwald A, Kurz K, Michgehl U, et al. Epstein–Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features. British Journal of Haematology [Internet]. 2021 Oct 6; 196(3): 681–9. doi: 10.1111/bjh.17874.
Singh S, Patel S, Sahu C, Ghoshal U, Verma H. A three year Seroepidemiological and molecular study of Epstein –Barr virus infection among different age groups with hematological malignancies in a Tertiary care centre of North India (2017-2019). Journal of Family Medicine and Primary Care [Internet]. 2021; 10(1): 373. doi: 10.4103/jfmpc.jfmpc_1594_20.
Anderson AG, Gaffy CB, Weseli JR, Gorres KL. Inhibition of Epstein-Barr Virus Lytic Reactivation by the Atypical Antipsychotic Drug Clozapine. Viruses [Internet]. 2019 May 17; 11(5): 450. doi: 10.3390/v11050450.
Messick TE, Smith GR, Soldan SS, McDonnell ME, Deakyne JS, Malecka KA, et al. Structure-based design of small-molecule inhibitors of EBNA1 DNA binding blocks Epstein-Barr virus latent infection and tumor growth. Science Translational Medicine [Internet]. 2019 Mar 6; 11(482). doi: 10.1126/scitranslmed.aau5612.
Liao HM, Liu H, Chin PJ, Li B, Hung GC, Tsai S, et al. Epstein-Barr Virus in Burkitt Lymphoma in Africa Reveals a Limited Set of Whole Genome and LMP-1 Sequence Patterns: Analysis of Archival Datasets and Field Samples From Uganda, Tanzania, and Kenya. Frontiers in Oncology [Internet]. 2022 Mar 7;12. doi: 10.3389/fonc.2022.812224.
Xian RR, Kinyera T, Otim I, Sampson JN, Nabalende H, Legason ID, et al. Plasma EBV DNA: A Promising Diagnostic Marker for Endemic Burkitt Lymphoma. Frontiers in Oncology [Internet]. 2021 Dec 14; 11: 804083. doi: 10.3389/fonc.2021.804083.
Torres Coral, Santana Josefina, Bravo Rodrigo, Córdova Luis, Rodríguez Ximena, Mardones Marcelo. Linfoma de Burkitt asociado a Virus de la Inmunodeficiencia Humana. Reporte de un caso clínico. Rev. Clin. Periodoncia Implantol. Rehabil. Oral [Internet]. 2019 Dic; 12(3): 148-150. doi: http://dx.doi.org/10.4067/S0719-01072019000300148.
Salud S de. Linfoma, enfermedad oncológica que puede ser curable [Internet]. gob.mx. Disponible en: https://www.gob.mx/salud/es/articulos/linfoma-enfermedad-oncologica-que-puede-ser-curable?idiom=es.
Cerron-Vela CR, Araujo-Banchon WJ. Linfoma de Burkitt de la calota craneana: a propósito de un caso. Revista de la Facultad de Ciencias Médicas de Córdoba [Internet]. 2020 Apr 14; 77(2): 106–9. doi: https://doi.org/10.31053/1853.0605.v77.n2.26764.
Pourghasemian M, Amin Danandeh Mehr E, Elaheh Alavizadeh, Roosta Y, Behzadi F. Primary bilateral ovarian involvement in Burkitt’s lymphoma with an adnexal Torsion‐like manifestation: A case report. Clinical Case Reports [Internet]. 2021 Nov 1; 9(11). doi: 10.1002/ccr3.5058.
Goel AN, Filimonov A, Teruya-Feldstein J, Salib C, Rousso JJ, Hackett AM, et al. Burkitt lymphoma of the nasopharynx causing life-threatening airway obstruction: A case report. American Journal of Otolaryngology [Internet]. 2021; 42(4): 102977. doi: 10.1016/j.amjoto.2021.102977.
Perkins AS, Friedberg JW. Burkitt Lymphoma in Adults. Hematology [Internet]. 2008 Jan 1;2008(1):341–8. doi: 10.1182/asheducation-2008.1.341. Disponible en: https://ashpublications.org/hematology/article/2008/1/341/95852/Burkitt-Lymphoma-in-Adults.
Pannone G, Zamparese R, Pace M, Pedicillo M, Cagiano S, Somma P, et al. The role of EBV in the pathogenesis of Burkitt’s Lymphoma: an Italian hospital based survey. Infectious Agents and Cancer [Internet]. 2014; 9(1): 34. doi: 10.1186/1750-9378-9-34.
Stepniak A, Piotr Czuczwar, Piotr Szkodziak, Wozniakowska E, Wozniak S, Paszkowski T. Primary ovarian Burkitt’s lymphoma: a rare oncological problem in gynaecology: a review of literature. Archives of gynecology and obstetrics [Internet]. 2017 Aug 2; 296(4): 653–60. doi: 10.1007/s00404-017-4478-6.
Molyneux EM, Rochford R, Griffin B, Newton R, Jackson G, Menon G, et al. Burkitt’s lymphoma. The Lancet [Internet]. 2012 Mar; 379(9822): 1234–44. doi: 10.1016/S0140-6736(11)61177-X. [
Storck K, Brandstetter M, Keller U, Knopf A. Clinical presentation and characteristics of lymphoma in the head and neck region. Head & Face Medicine [Internet]. 2019 Jan 3; 15(1). doi: 10.1186/s13005-018-0186-0.
Ospina Pérez M, Muñetón Peña CM. Alteraciones del gen c-Myc en la oncogénesis. Iatreia [Internet]. 2011 Dec; 24(4): 389-401. Disponible en: http://www.scielo.org.co/scielo.php?script=sci_arttext&pid=S0121-07932011000400006&lng=en.
Gálvez Paz CN, Mendoza Goycochea ME, Espíritu N, Paz Carrillo EM, Gálvez Paz CN, Mendoza Goycochea ME, et al. Características clínicas, epidemiológicas y patológicas de los linfomas en pacientes del Instituto Nacional de Salud del Niño de Breña - Perú, 2015-2019. Anales de la Facultad de Medicina [Internet]. 2021 Mar 1; 82(1): 27–33. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1025-55832021000100027.
Bidot S, Asakrah, S. Burkitt lymphoma [Internet]. www.pathologyoutlines.com. 2021 Disponible en: https://www.pathologyoutlines.com/topic/lymphomaburkitt.
Melenotte C, Mezouar S, Mège JL, Gorvel JP, Kroemer G, Raoult D. Bacterial infection and non-Hodgkin’s lymphoma. Critical Reviews in Microbiology [Internet]. 2020 May 1; 46(3): 270–87. doi: 10.1080/1040841X.2020.1760786.
Coelho R, Gonçalves R, Costa J, Macedo G. Burkitt’s Lymphoma Diagnosed by Colonoscopy in Immunocompetent Patient. GE Portuguese Journal of Gastroenterology [Internet]. 2015 May 1; 22(3): 130–1. doi: 10.1016/j.jpge.2015.02.002.
Latorre-Rodríguez Andrés Ricardo, Rodríguez-Chavarría María Angélica, Acosta-Forero Bernarda Jinneth, Ricaurte-Guerrero Orlando. Linfoma no Hodgkin primario de ovario: reporte de caso y revisión de la bibliografía. Ginecol. obstet. Méx. [Internet]. 2022; 90(9): 794-802. doi: 10.24245/gom.v90i9.5722.
Aragón Flores M, Pérez Zincer F, Pérez Salvador A, Roldán A, Gaspar López A. Linfoma de Burkitt, presentación de un caso y abordaje diagnóstico. Revista de Sanidad Militar [Internet]. 2012; 66: 272–7. Disponible en: https://www.imbiomed.com.mx/articulo.php?id=88564.
Arboine Ciphas Maureen. Linfoma de burkitt: a propósito de un caso. Med. leg. Costa Rica [Internet]. 2017 Mar; 34(1): 325-331. Disponible en: http://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S1409-00152017000100325&lng=en.
Jacobson C, LaCasce A. How I treat Burkitt lymphoma in adults. Blood [Internet]. 2014 Nov 6; 124(19): 2913–20. doi: 10.1182/blood-2014-06-538504.
Arseneau JC, Canellos GP, Banks PA, Berard CW, Gralnick HR, DeVita VT. American Burkitt’s lymphoma: A clinicopathologic study of 30 cases [Internet]. 1975 Mar 1; 58(3): 314–21. doi: 10.1016/0002-9343(75)90598-7.
Graham BS, Lynch DT. Burkitt Lymphoma. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing. 2023. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK538148/.
Ferry JA. Burkitt’s Lymphoma: Clinicopathologic Features and Differential Diagnosis. The Oncologist [Internet]. 2006 Apr 1; 11(4): 375–83. doi: 10.1634/theoncologist.11-4-375.
Suárez A. Síndrome de lisis tumoral: un enfoque pediátrico. Revista Colombiana de Cancerología [Internet]. 2004 Jun 1; 8(2): 31–9. Disponible en: http://www.scielo.org.co/pdf/rcc/v8n2/v8n2a05.pdf.
De Soto Cardenal M, Coronel Villarán MJ, Prat Gutierrez R. Linfoma de Burkitt ovárico bilateral. Progresos de Obstetricia y Ginecología [Internet]. 2015 Dec. Disponible en: https://sego.es/documentos/progresos/v59-2016/n5/13_Linfoma.pdf.
Alexander CJ, Wake LM. Educational Case: Burkitt Lymphoma. Academic Pathology [Internet]. 2019 Jan 1; 6: 237428951988473. doi: 10.1177/2374289519884733.
Chong Y, Kim TE, Cho U, Jin MS, Yim K, Thakur N, et al. Comparison of Ki-67 Labeling Index Patterns of Diffuse Large B-Cell Lymphomas and Burkitt Lymphomas Using Image Analysis: A Multicenter Study. Diagnostics [Internet]. 2021 Feb 19; 11(2): 343. doi: 10.3390/diagnostics11020343.
Hambach J, Riecken K, Cichutek S, Schütze K, Albrecht B, Petry K, et al. Targeting CD38-Expressing Multiple Myeloma and Burkitt Lymphoma Cells In Vitro with Nanobody-Based Chimeric Antigen Receptors (Nb-CARs). Cells [Internet]. 2020 Jan 29; 9(2): 321–1. doi: 10.3390/cells9020321. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072387/.
Lindström MS, Klangby U, Wiman KG. p14ARF homozygous deletion or MDM2 overexpression in Burkitt lymphoma lines carrying wild type p53. Oncogene [Internet]. 2001 Apr; 20(17): 2171–7. doi: 10.1038/sj.onc.1204303.
Klanova M, Dmitry Kazantsev, Pokorna E, Zikmund T, Karolova J, Behounek M, et al. Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas. Molecular Cancer Therapeutics [Internet]. 2021 Nov 2; 21(1): 89–99. doi: 10.1158/1535-7163.MCT-21-0511.
Schwabkey ZI, Najla Al Ali, Chan O, Sallman DA, Padron E, Kuykendall AT, et al. Fluorescence in Situ Hybridization (FISH) Utility for Risk Score Assessment in Patients With MDS With Normal Metaphase Karyotype. Clinical Lymphoma Myeloma & Leukemia [Internet]. 2021 Jan 1; 21(1): e52–6. doi: 10.1016/j.clml.2020.08.012.
Chrzanowska NM, Kowalewski J, Lewandowska MA. Use of Fluorescence In Situ Hybridization (FISH) in Diagnosis and Tailored Therapies in Solid Tumors. Molecules [Internet]. 2020 Apr 17; 25(8). doi: 10.3390/molecules25081864.
Asif A, Mushtaq S, Hassan U, Akhtar N, Hussain M, Azam M, et al. Fluorescence in Situ Hybridization (FISH) for Differential Diagnosis of Soft Tissue Sarcomas. Asian Pacific Journal of Cancer Prevention: APJCP [Internet]. 2018; 19(3): 655–60. doi: 10.22034/APJCP.2018.19.3.655.
Savic S, Bubendorf L. Common Fluorescence In Situ Hybridization Applications in Cytology. Archives of Pathology & Laboratory Medicine [Internet]. 2016 Dec 1; 140(12): 1323–30. doi: 10.5858/arpa.2016-0202-RA.
Nelson M, Perkins SL, Davé BJ, Coccia PF, Bridge JA, Lyden E, et al. An increased frequency of 13q deletions detected by fluorescencein situhybridization and its impact on survival in children and adolescents with Burkitt lymphoma: results from the Children’s Oncology Group study CCG-5961. British Journal of Haematology [Internet]. 2010 Feb 1; 148(4): 600–10. doi: 10.1111/j.1365-2141.2009.07967.x.
Robertson ES. Burkitt’s Lymphoma. Springer eBooks. Springer Nature [Internet]. 2013. Disponible en: https://link.springer.com/book/10.1007/978-1-4614-4313-1.